Follow-up of 208 tuberculosis patients treated in 2004 with the assistance of TB-info® software

被引：2

作者：

Bourgarit, A. ^{[1
]}

Mallet, H. -P. ^{[2
]}

Keshtmand, H. ^{[1
,2
]}

De Castro, N. ^{[1
]}

Rambeloarisoa, J. ^{[1
]}

Fain, O. ^{[3
]}

Antoun, F. ^{[2
]}

Picard, C. ^{[1
]}

Rocher, G. ^{[5
]}

Che, D. ^{[4
]}

Farge, D. ^{[1
]}

机构：

[1] Hop St Louis, F-75010 Paris, France

[2] DASES, F-75012 Paris, France

[3] Hop Jean Verdier, F-93143 Bondy, France

[4] Inst Veille Sanit, F-94415 St Maurice, France

[5] Ctr Med Fernand Besancon, F-95270 St Martin Du Tertre, France

来源：

REVUE DE MEDECINE INTERNE | 2009年 / 30卷 / 10期

关键词：

Tuberculosis; Antituberculosis treatment; Outcome; Therapeutic monitoring; Software;

D O I：

10.1016/j.revmed.2009.03.362

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction. - The impact of the TB-info (R) software was assessed on the care of patients treated with antituberculosis regimen (ATT). Methods. - Cohort study of patients with tuberculosis who received an ATT in 2004 in two hospitals and five medical centres in Paris. Follow-up was implemented with the TB-Info (R) software. Data were compared to those of the 1999-2003 cohort. Results. - Two hundred and nine ATT were initiated in 2004, with a mean duration of 7.2 months. Demographic and clinical data reflected this population precariousness: 79% were foreign-born, 25% lived in institutions and half of them had no or unusual health insurance. Compared to the previous cohort, viral co-infections were tested in more than 80% cases and showed association with HIV, HBV or HCV in 11, 10 and 5% of the patients, respectively. Twenty-one patients were lost for follow-up (11%) and 76% of the smear-positive pulmonary tuberculosis therapies were declared successful but only 34% were declared cured with the WHO criteria. Conclusion. - Analysis of the data obtained with TB-info (R) software showed an improvement of tuberculosis patients care with more co-infection tested and less lost for follow-up. These results confirm the usefulness of this software for patients care and assessment of physicians practice in France. (C) 2009 Societe national efrancaise de medecine interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

引用

页码：841 / 846

页数：6

共 12 条

[1] [Anonymous], 2003, REV MAL RESP, V20, pS27
[2] ANTOUN F, 2005, B EPIDEMIOL HEBD, V17, P70
[3] BAYOLHONNET G, 2001, B EPIDEMIOL HEBD, V41, P199
[4] Che D, 2004, BEH, V4, P13
[5] CHE D, 2006, BEH, V18, P121
[6] *CONS SUP HYG PUBL, 2006, AV REL DECL OBL ISS
[7] Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective
Ditah, I. C.
Reacher, M.
Palmer, C.
Watson, J. M.
Innes, J.
Kruijshaar, M. E.
Luma, H. N.
Abubakar, I.
[J]. THORAX, 2008, 63 (05) : 440 - 446
[8] FARGE D, 2005, B EPIDEMIOL HEBD, V17, P81
[9] *HAUT AUT SANT, 2007, 29 ALD HAUT AUT SANT
[10] Standardized tuberculosis treatment outcome monitoring in Europe
Veen, J
Raviglione, M
Rieder, HL
Migliori, GB
Graf, P
Grzemska, M
Zalesky, R
[J]. EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (02) : 505 - 510

← 1 2 →